Lewes, DE -- (SBWire) -- 07/22/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: STELLAR BIOTECH INC (OTCMKTS:SBOTF), Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY), Arch Therapeutics Inc (OTCBB:ARTH), Globalstar, Inc. (OTCMKTS:GSAT)

STELLAR BIOTECH INC (OTCMKTS:SBOTF) gained 9.65%, trading on 592,460 shares to end the trade at $1.02. The stock changed hands in a range of $0.95 to $1.05, bringing its market capitalization at about $49.22 million. If we look at its trading history of past 52 weeks, the share price suffered low of $0.19 and was moved to maximum level of $1.05. Stellar Biotechnologies, Inc. produces and markets keyhole limpet hemocyanin (KLH), as well as develops technology related to the culture and production of KLH and subunit KLH formulations in the United States and Europe.

What was the Moving Force behind SBOTF on Bullish Run? Read This Research Report

Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY) declined -0.66% to complete the trading session at $9.01 with a total volume of 66,745 shares. The stock, on average, trades on a volume of 149,072 shares. It floated in a range of $9.00 to $9.26 during last trading session with a beta value of 1.00. Its market capitalization now moved to about $3.35 billion. In the past 52 weeks, the share price has not declined below $8.50 and above $11.53. Telecom Corporation of New Zealand Limited, together with its subsidiaries, provides telecommunications services,information technology (IT) services, and network services in New Zealand and Australia.

Is it the Right to Grab NZTCY after the Recent Slump? Get Free Trend Analysis Here

Arch Therapeutics Inc (OTCBB:ARTH) added 6.22% and was in a range of $0.44-$0.51 before closing at $0.478. The stock completed the day with a total volume of 1.52 million shares versus an average volume of 1.63 million shares. The share price hit its 52-week low of $0.012 and $1.35 was the best price. Arch Therapeutics, Inc. operates as a life science company developing liquid polymers containing tiny peptides intended to form gel-like barriers over surgical wounds to stop or control bleeding. The company was formerly known as Clear Nano Solutions, Inc. It was founded in 2006 and is based in Natick, Massachusetts.

For How Long ARTH will fight for Profitability? Read This Trend Analysis report

Globalstar, Inc. (OTCMKTS:GSAT) added 0.79% yesterday, bringing its market capitalization around $312.56 million. The share price after opening at $0.64 made a high of $0.64 and hovered above $0.63 to end the day at $0.635. The total number of shares changed hands during the session was 1.31 million shares as compared to average trading volume of 1.28 million shares. Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational, emergency response, and other applications; fixed voice and data satellite communications services in rural villages, ships, industrial and commercial sites.

For How Long GSAT Gloss will Attract Investors? Find out via this report

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/